After 2 years of the COVID-19 pandemic, translating One Health into action is urgent

Thierry Lefrançois(Centre de Coopération Internationale en Recherche Agronomique pour le Développement), Bruno Lina(Université Claude Bernard Lyon 1), Laëtitia Atlani-Duault(Université Paris Cité), Yazdan Yazdanpanah(Inserm), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Daniel Benamouzig(Centre National de la Recherche Scientifique), Pierre-Louis Druais(Santé Publique France), Denis Malvy(Université de Bordeaux)
The Lancet
October 24, 2022
10.1016/s0140-6736(22)01840-2
Cited by 104

Related Papers

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
High-Resolution Measurements of Face-to-Face Contact Patterns in a Primary School
|PLoS ONE|2011|857
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
|The Lancet|1999|667